Neon Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 1.27 Cr
- Company Age 42 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 104.50 Cr
- Satisfied Charges ₹ 824.17 Cr
- Revenue Growth 23.78%
- Profit Growth 4.29%
- Ebitda 4.84%
- Net Worth 18.34%
- Total Assets 15.36%
About Neon Laboratories
Neon Laboratories Limited (NLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 June 1982 and has a history of 42 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Neon Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.27 Cr.
The company currently has active open charges totaling ₹104.50 Cr. The company has closed loans amounting to ₹824.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashokkumar Jain, Uttamchand Jain, Pravin Jain, and Four other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH1982PLC027493
- Company No.
027493
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Neon Laboratories Limited offer?
Neon Laboratories Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anesthetic, Antibacterial Drugs, Clindamycin & Nicotinamide Gel, Sexual Wellness, Men Performance Enhancers, Popular Category.
Who are the key members and board of directors at Neon Laboratories?
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhay Jain ![]() | Director | 05-Feb-2007 | Current |
Ashokkumar Jain ![]() | Director | 01-Apr-2017 | Current |
Uttamchand Jain ![]() | Director | 22-Jun-1982 | Current |
Pravin Jain ![]() | Director | 06-Feb-1996 | Current |
Kishor Solanki ![]() | Director | 30-Mar-2015 | Current |
Usha Jain ![]() | Director | 30-Mar-2015 | Current |
Financial Performance of Neon Laboratories.
Neon Laboratories Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.78% increase. The company also saw a slight improvement in profitability, with a 4.29% increase in profit. The company's net worth Soared by an impressive increase of 18.34%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Neon Laboratories?
In 2024, Neon Laboratories had a promoter holding of 99.90% and a public holding of 0.10%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹104.50 Cr
₹824.17 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 100.00 Cr
- Standard Chartered Bank : 4.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Aug 2023 | State Bank Of India | ₹75.00 Cr | Open |
14 Oct 2021 | Standard Chartered Bank | ₹4.50 Cr | Open |
06 Oct 2021 | State Bank Of India | ₹25.00 Cr | Open |
23 Aug 2018 | Others | ₹1.50 M | Satisfied |
24 Jul 2018 | Others | ₹5.60 M | Satisfied |
How Many Employees Work at Neon Laboratories?
Neon Laboratories has a workforce of 2252 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Neon Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neon Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.